GL
Globe LifePrevious close
159.08
Change
−1.37 / −0.85%
P/E (TTM) ?
10.4
Market Cap
$12.2B
1M
−3.97%
S&P 500 −0.91% over same period
Volume / Avg Volume
603K / 835K
0.72× average
Latest earnings analysisFY2026 Q2Reported 2026-07-22
Globe Life Q2 2026: revenue up 8.0%, EPS $3.65, outlook raised
Globe Life grew Q2 2026 revenue 8.0% to $1.60 billion and lifted GAAP EPS 19.7% to $3.65, but that still trailed the $3.7866 consensus estimate. Health premium did the heavy lifting, up 16.0%, while health underwriting margin was nearly flat. Read the quarter as solid top-line growth with a softer per-share result than the headline implies.
Read the full analysis →Revenue$1.60BYoY +8.00%
EPS (non-GAAP)$3.61Missest. $3.79
Next-day move−7.02%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-22 | $1.6B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-22 | $1.6B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-04 | $6.0B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-22 | $1.5B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-23 | — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-30 | $1.5B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 47 of its 5-year rangeMid-range
5-year range 7.9 – 12.7 · Median 10.5
Last 4 quarters: $881M in buybacks + $90.6M in dividends, 7.97% of market cap combined
P/E (TTM)
10.4
P/B
2.0
P/S
2.0
Dividend Yield
0.74%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.4% on average on the first trading day after, rising 4 times
Most recent −7.02%
Volatility & Correlation
1-year beta 0.16 · Correlation with S&P 500 0.08Low beta
Annualized volatility 24% vs. 12% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 5 · $17.6MNet selling $17.6M
- 10-23MAJORS MICHAEL CLAYEVP - Chief Strategy OfficerSell$2.2M14,377 shares · Avg price 154.48
- 09-22Hensley Robert EdwardEVP & Chief Investment OfficerSell$1.7M10,000 shares · 2 trades · Avg price 170.07
- 08-07MITCHELL ROBERT BRIANEVP, General Counsel and CROSell$4.2M23,000 shares · 3 trades · Avg price 183.34
- 07-31Darden James MatthewCo-Chairman & CEOSell$9.1M50,000 shares · 2 trades · Avg price 182.43
- 03-02Hensley Robert EdwardEVP & Chief Investment OfficerSell$0.37M2,569 shares · Avg price 145.04
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 1.60 | +8.0% | — | 0.29 | 3.65 |
| FY2026 Q1 | 1.56 | +5.3% | — | 0.27 | 3.39 |
| FY2025 Q4 | 1.52 | +3.6% | — | 0.27 | 3.28 |
| FY2025 Q3 | 1.51 | +4.0% | — | 0.39 | 4.73 |
| FY2025 Q2 | 1.48 | +2.8% | — | 0.25 | 3.05 |
| FY2025 Q1 | 1.48 | +4.5% | — | 0.25 | 3.01 |
| FY2024 Q4 | 1.47 | +3.6% | — | 0.26 | 3.00 |
| FY2024 Q3 | 1.46 | +5.2% | — | 0.30 | 3.44 |
| FY2024 Q2 | 1.44 | +8.6% | — | 0.26 | 2.83 |
| FY2024 Q1 | 1.42 | +7.2% | — | 0.25 | 2.67 |
| FY2023 Q4 | 1.42 | +6.0% | — | 0.27 | 2.88 |
| FY2023 Q3 | 1.38 | +6.7% | — | 0.26 | 2.68 |